These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23794088)

  • 21. Exfoliative cytology of primary and metastatic Wilms tumors.
    Hajdu SI
    Acta Cytol; 1971; 15(4):339-42. PubMed ID: 4331021
    [No Abstract]   [Full Text] [Related]  

  • 22. Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect.
    Zhu S; Waguespack M; Barker SA; Li S
    Clin Cancer Res; 2007 Jul; 13(14):4252-60. PubMed ID: 17634555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
    Ramburan A; Hadley GP; Govender D
    Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
    Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
    Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral Wilms' tumors: a single-center experience with 19 cases.
    Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
    J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX2 expression in Wilms tumors and other childhood neoplasms.
    Davis JL; Matsumura L; Weeks DA; Troxell ML
    Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the activation of Stat1 by the interferon-gamma receptor complex.
    Krause CD; He W; Kotenko S; Pestka S
    Cell Res; 2006 Jan; 16(1):113-23. PubMed ID: 16467883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors.
    Desrosiers RR; Rivard ME; Grundy PE; Annabi B
    Pediatr Blood Cancer; 2006 Jan; 46(1):40-9. PubMed ID: 16106426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
    Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
    Lynch RA; Etchin J; Battle TE; Frank DA
    Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [1 of the variants of Wilms' tumor].
    Sokolova IN; Lebedev VI
    Arkh Patol; 1981; 43(10):49-53. PubMed ID: 6274278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo.
    Kaganoi J; Watanabe G; Okabe M; Nagatani S; Kawabe A; Shimada Y; Imamura M; Sakai Y
    Ann Surg Oncol; 2007 Apr; 14(4):1405-15. PubMed ID: 17195908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A metastasizing model of anaplastic human Wilms tumor in the nude mouse.
    Marvin MR; Kayton ML; O'Toole KM; Rowe DH; DeRosa C; Kindred A; Trokhan S; Chabot J; Kandel JJ
    Eur J Pediatr Surg; 1998 Oct; 8(5):295-8. PubMed ID: 9825240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
    Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
    J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFN-gamma-mediated inhibition of COX-2 expression in the placenta from term and preterm labor pregnancies.
    Hanna N; Bonifacio L; Reddy P; Hanna I; Weinberger B; Murphy S; Laskin D; Sharma S
    Am J Reprod Immunol; 2004 Apr; 51(4):311-8. PubMed ID: 15212685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.